These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6244276)

  • 41. [Mode of action of cyclic amp in prokaryotes and eukaryotes, CAP and cAMP-dependent protein kinases].
    de Gunzburg J
    Biochimie; 1985 Jun; 67(6):563-82. PubMed ID: 2413906
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular structure and characterization of bovine heart protein kinase.
    Rosen OM; Erlichman J; Rubin CS
    Adv Cyclic Nucleotide Res; 1975; 5():253-63. PubMed ID: 165669
    [No Abstract]   [Full Text] [Related]  

  • 43. The kinetics of the interaction between cyclic AMP and the regulatory moiety of protein kinase II. Evidence for interaction between the binding sites for cyclic AMP.
    Ogreid D; Døskeland SO
    FEBS Lett; 1981 Jul; 129(2):282-6. PubMed ID: 6269881
    [No Abstract]   [Full Text] [Related]  

  • 44. Physical and chemical properties of rabbit muscle phosphofructokinase cross-linked with dimethyl suberimidate.
    Lad PM; Hammes GG
    Biochemistry; 1974 Oct; 13(22):4530-7. PubMed ID: 4371809
    [No Abstract]   [Full Text] [Related]  

  • 45. Dissociation of rabbit muscle cyclic AMP-dependent protein kinase into catalytic and regulatory subunits by p-chloromercuribenzoate and methylmercuric chloride.
    Murray AW; Froscio M; Rogers A
    FEBS Lett; 1974 Nov; 48(2):238-40. PubMed ID: 4373289
    [No Abstract]   [Full Text] [Related]  

  • 46. Mutations that prevent cyclic nucleotide binding to binding sites A or B of type I cyclic AMP-dependent protein kinase.
    Ogreid D; Døskeland SO; Gorman KB; Steinberg RA
    J Biol Chem; 1988 Nov; 263(33):17397-404. PubMed ID: 2846564
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ligand-enzyme interactions and enzyme regulation.
    Bennick A; Dwek RA; Griffiths JR; Radda GK
    Ann N Y Acad Sci; 1973 Dec; 222():175-91. PubMed ID: 4361854
    [No Abstract]   [Full Text] [Related]  

  • 48. Activation of protein kinase isozymes by cyclic nucleotide analogs used singly or in combination. Principles for optimizing the isozyme specificity of analog combinations.
    Ogreid D; Ekanger R; Suva RH; Miller JP; Sturm P; Corbin JD; Døskeland SO
    Eur J Biochem; 1985 Jul; 150(1):219-27. PubMed ID: 2990925
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spectrometric and biological data of 1, N6-ethenoadenosine 3', 5'-cyclic monophosphate.
    Wombacher H; Reuter-Smerdka M
    Z Naturforsch C Biosci; 1976; 31(1-2):18-20. PubMed ID: 179233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Physicochemical studies on the interaction of the calcium-binding protein (troponin C) with the inhibitory protein (troponin I) and calcium ions.
    McCubbin WD; Mani RS; Kay CM
    Biochemistry; 1974 Jun; 13(13):2689-94. PubMed ID: 4277059
    [No Abstract]   [Full Text] [Related]  

  • 51. A histone cross-complexing pattern.
    D'Anna JA; Isenberg I
    Biochemistry; 1974 Nov; 13(24):4992-7. PubMed ID: 4474009
    [No Abstract]   [Full Text] [Related]  

  • 52. [Separation of catalytic and regulatory subunits of pigeon breast muscle protein kinase].
    Iusupova GI; Meshkova NP
    Biokhimiia; 1978 Jan; 43(1):89-93. PubMed ID: 203342
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies of functional domains of the regulatory subunit from cAMP-dependent protein kinase isozyme I.
    Rannels SR; Corbin JD
    J Cyclic Nucleotide Res; 1980; 6(3):201-15. PubMed ID: 6255020
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of phosphorylation on the regulatory subunit of the type I cAMP-dependent protein kinase.
    Geahlen RL; Allen SM; Krebs EG
    J Biol Chem; 1981 May; 256(9):4536-40. PubMed ID: 6260803
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conformational transitions in glycogen phosphorylase reported by covalently bound pyridoxamine derivatives.
    Feldmann K; Gaugler BJ; Winkler H; Helmreich EJ
    Biochemistry; 1974 May; 13(10):2222-30. PubMed ID: 4826893
    [No Abstract]   [Full Text] [Related]  

  • 56. Regulation of protein kinase and phosphoprotein phosphatase by cyclic AMP and cyclic AMP antagonist.
    Wasner HK
    FEBS Lett; 1975 Sep; 57(1):60-3. PubMed ID: 170131
    [No Abstract]   [Full Text] [Related]  

  • 57. Mapping cyclic AMP binding sites on type I and type II cyclic AMP-dependent protein kinases using 2-substituted derivatives of cyclic AMP.
    Yagura TS; Sigman CC; Sturm PA; Reist EJ; Johnson HL; Miller JP
    Biochem Biophys Res Commun; 1980 Jan; 92(2):463-7. PubMed ID: 6243941
    [No Abstract]   [Full Text] [Related]  

  • 58. Rates of dissociation and recombination of the subunits of bovine thyrotropin.
    Ingham KC; Aloj SM; Edelhoch H
    Arch Biochem Biophys; 1974 Aug; 163(2):589-99. PubMed ID: 4472276
    [No Abstract]   [Full Text] [Related]  

  • 59. Binding of two fluorescent cAMP analogues to type I and II regulatory subunits of cAMP-dependent protein kinases.
    Mucignat-Caretta C; Caretta A
    Biochim Biophys Acta; 1997 Jun; 1357(1):81-90. PubMed ID: 9202178
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Arginine 210 is not a critical residue for the allosteric interactions mediated by binding of cyclic AMP to site A of regulatory (RIalpha) subunit of cyclic AMP-dependent protein kinase.
    Steinberg RA; Symcox MM; Sollid S; Ogreid D
    J Biol Chem; 1996 Nov; 271(44):27630-6. PubMed ID: 8910352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.